1. Home
  2. MRCY vs VKTX Comparison

MRCY vs VKTX Comparison

Compare MRCY & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRCY
  • VKTX
  • Stock Information
  • Founded
  • MRCY 1981
  • VKTX 2012
  • Country
  • MRCY United States
  • VKTX United States
  • Employees
  • MRCY N/A
  • VKTX N/A
  • Industry
  • MRCY
  • VKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MRCY
  • VKTX Health Care
  • Exchange
  • MRCY Nasdaq
  • VKTX Nasdaq
  • Market Cap
  • MRCY 4.6B
  • VKTX 3.8B
  • IPO Year
  • MRCY 1998
  • VKTX 2015
  • Fundamental
  • Price
  • MRCY $70.17
  • VKTX $36.41
  • Analyst Decision
  • MRCY Buy
  • VKTX Strong Buy
  • Analyst Count
  • MRCY 7
  • VKTX 14
  • Target Price
  • MRCY $76.43
  • VKTX $87.07
  • AVG Volume (30 Days)
  • MRCY 639.3K
  • VKTX 4.2M
  • Earning Date
  • MRCY 11-04-2025
  • VKTX 10-22-2025
  • Dividend Yield
  • MRCY N/A
  • VKTX N/A
  • EPS Growth
  • MRCY N/A
  • VKTX N/A
  • EPS
  • MRCY N/A
  • VKTX N/A
  • Revenue
  • MRCY $932,798,000.00
  • VKTX N/A
  • Revenue This Year
  • MRCY $6.17
  • VKTX N/A
  • Revenue Next Year
  • MRCY $8.23
  • VKTX N/A
  • P/E Ratio
  • MRCY N/A
  • VKTX N/A
  • Revenue Growth
  • MRCY 8.63
  • VKTX N/A
  • 52 Week Low
  • MRCY $37.28
  • VKTX $18.92
  • 52 Week High
  • MRCY $85.33
  • VKTX $56.25
  • Technical
  • Relative Strength Index (RSI)
  • MRCY 44.78
  • VKTX 52.10
  • Support Level
  • MRCY $65.04
  • VKTX $32.90
  • Resistance Level
  • MRCY $70.89
  • VKTX $43.15
  • Average True Range (ATR)
  • MRCY 2.65
  • VKTX 2.41
  • MACD
  • MRCY -0.26
  • VKTX -0.56
  • Stochastic Oscillator
  • MRCY 45.25
  • VKTX 32.98

About MRCY Mercury Systems Inc

Mercury Systems Inc is a commercial technology company serving the aerospace and defense industry. The company envisions, creates, and delivers secure open architecture solutions powering a broad range of mission-critical applications in challenging and demanding environments. Its Mercury Processing Platform spans the full breadth of signal processing from radio frequency front end to the human-machine interface to convert meaningful data, gathered in remote and hostile environments, into critical decisions. The company manufactures components, products, modules, and subsystems and sells to defense prime contractors, the U.S. government, original equipment manufacturers, and commercial aerospace companies. Geographically, it derives maximum revenue from the United States.

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Share on Social Networks: